Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Doctors And Hospitals Look For Ways To Cut Costs, Improve Quality
The "patient-centered" practices movement is growing in popularity, the New York Times reports. Primary care physicians in the practices "spend more time with patients, emphasize prevention and education" to keep patients healthy and "can handle many medical problems without referrals to specialists." Often, "this kind of care can reduce a patient"s medical bills." Dr. Jose Batlle, a doctor in the Bronx, for example, gives patients his cell phone number and helps his patients cut down on the number of prescription drugs that have him prescribed to them by multiple specialists. "I prefer to keep them healthy than treat them when they are sick," Batlle says.
generic viagra online
AARP Presses Lawmakers To Support Long Term Care
AARP Executive Vice President Nancy LeaMond released
plastic surgery before after
News of the day
Emergent BioSolutions Receives FDA Approval Extending Shelf Life Of BioThrax (Anthrax Vaccine Adsorbed) To 4 Years
Emergent BioSolutions Inc. (NYSE:EBS) announced that its flagship product, BioThrax® (Anthrax Vaccine Adsorbed), has been granted a shelf life extension from 3 to 4 years by the U.S. Food and Drug Administration (FDA). Based on this approval, Emergent has achieved a contract milestone warranting a payment of approximately $30 million for doses previously delivered to the Strategic National Stockpile (SNS) under the terms of the company"s existing BioThrax procurement contracts with the Department of Health and Human Services (HHS). This amount is expected to be recognized as revenue in the second quarter of 2009. In addition, FDA approval of 4-year expiry dating results in an immediate price increase for the future delivery of BioThrax doses under the current contract as well as under the follow-on multi-year contract, valued at $405 million, for the delivery of 14.5 million doses of BioThrax.
Endocrinology

FDA Approve One-Pill Version Of Plan B, Sets Over-The-Counter Access At Age 17

FDA approved Teva Pharmaceuticals" Plan B One-Step -- a single-pill version of the two-pill dose emergency contraceptive product Plan B -- and lowered the limit for over-the-counter purchase of the drug to age 17, the company announced on Monday, the AP/Yahoo! Finance reports (AP/Yahoo! Finance, 7/13). Individuals ages 16 and younger will be required to obtain prescriptions to purchase Plan B, which reduces the chance of pregnancy when taken within 72 hours of sexual intercourse (Teva Pharmaceuticals release, 7/13). Teva said the one-pill version will be available at retail pharmacies in August (AP/Yahoo! Finance, 7/13). Kelli Conlin, president of the National Institute for Reproductive Health, said, "Health care providers and women"s advocates have been eager for a one-pill emergency contraceptive for years and are happy to see it finally come to fruition" (Teva Pharmaceuticals release, 7/13).The expanded access to the medication comes several months after a federal court lifted restrictions put in place under former President George W. Bush that limited OTC sales to women ages 18 and older (AP/Yahoo! Finance, 7/13). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009